Dr Jane Cox

Biomarker research of liver damage is based on the assumption that the diseased liver will cause a specific change in the chemical compounds it metabolises (breaks down) or synthesises (produces) and that an alteration in concentration of such metabolites (Metabonomics) in blood or urine will provide an earlier marker of disease than is currently possible through routine tests. I am developing and applying state-of-the-art analytical chemistry techniques to improve the diagnosis and monitoring of liver diseases. I studied Chemistry at university and during my PhD studies I developed applications of nuclear magentic resonance (NMR) spectroscopy.

More on my research


The Foundation runs on donations. Every little helps us continue our work.